Oncology and Hematology - Global Oncology Academy

417-432 of 743

Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Project Oncology®
Stratifying Advanced Endometrial Cancer: Real-World Outcomes by Molecular Subtype
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
On the Frontlines of Prostate Cancer
Redefining mHSPC Treatment: From Monotherapy to Triplet Therapy Regimens
Daniel J. George, MD
- Daniel J. George, MD
ADT Monotherapy for mHSPC: How to Identify the Right Patients
ADT Monotherapy for mHSPC: How to Identify the Right Patients
On the Frontlines of Prostate Cancer
ADT Monotherapy for mHSPC: How to Identify the Right Patients
Daniel J. George, MD
- Daniel J. George, MD
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
On the Frontlines of Prostate Cancer
Evolving Treatment Patterns in mHSPC: Shifts in ARPi and Triplet Use
Daniel J. George, MD
- Daniel J. George, MD
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Advancing Patient-Centered Care in HER2-Positive Metastatic Breast Cancer
Megan Kruse, MD
- Megan Kruse, MD
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
On the Frontlines of Metastatic Breast Cancer
Optimizing Quality of Life in HER2+ Metastatic Breast Cancer
Megan Kruse, MD
- Megan Kruse, MD
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Project Oncology®
Refining First-Line Therapy in Advanced Endometrial Care: LEAP-001 Trial Results
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Global Oncology Academy
Recognizing and Addressing Rheumatic irAEs from Cancer Immunotherapies
Laura Cappelli, MD, MHS,MS
- Laura Cappelli, MD, MHS,MS
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Project Oncology®
Oral Contraceptives and Endometrial Cancer: Examining a Potential Dose-Response Protective Effect
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Clinician's Roundtable
Prostate Cancer and Cannabis Use: Exploring Results From a Case-Control Study
Ihtisham Ahmad
- Ihtisham Ahmad
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
On the Frontlines of Metastatic Breast Cancer
Balancing Efficacy and Tolerability in Metastatic Breast Cancer Treatment
Paolo Tarantino, MD
- Paolo Tarantino, MD
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
On the Frontlines of Metastatic Breast Cancer
Navigating Metastatic Breast Cancer Care: Key Factors in Decision-Making
Paolo Tarantino, MD
- Paolo Tarantino, MD
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
On the Frontlines of Prostate Cancer
Reducing Prostate Cancer Cell Production: The Role of Bipolar Androgen Therapy
Mohit Khera, M.D., M.B.A., M.P.H.
- Mohit Khera, M.D., M.B.A., M.P.H.
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Project Oncology®
Reducing Patient Time Burden in HER2+ Breast Cancer with Subcutaneous Trastuzumab/Pertuzumab
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
On the Frontlines of Prostate Cancer
Reevaluating Testosterone: A Paradigm Shift in Prostate Cancer Treatment
Mohit Khera, M.D., M.B.A., M.P.H.
- Mohit Khera, M.D., M.B.A., M.P.H.
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
On the Frontlines of Prostate Cancer
Prostate Cancer Care: Testosterone Therapy’s Impact on Biochemical Recurrence
Mohit Khera, M.D., M.B.A., M.P.H.
- Mohit Khera, M.D., M.B.A., M.P.H.

27/11